Evidence map›Paper›PMID 27564705›Full record

ArticlePloS one2016

Serum 25-Hydroxyvitamin D3 and Mammography Density among Mexican Women.

Amina Amadou, Carine Biessy, Sabina Rinaldi, Veronika Fedirko, Nada Assi, Martin Lajous, Eduardo Ortiz-Panozo, Elsa Yunes, Ruy Lopez-Ridaura, Gabriela Torres-Mejia and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Amina AmadouNutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
Carine BiessyNutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
Sabina RinaldiNutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
Veronika FedirkoDepartment of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.
Nada AssiNutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
Martin LajousCenter for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.
Eduardo Ortiz-PanozoCenter for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.
Elsa YunesCenter for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.
Ruy Lopez-RidauraCenter for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.
Gabriela Torres-MejiaCenter for Research on Population Health, National Institute of Public Health, Cuernavaca, Mexico.
Isabelle RomieuNutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
Instituto Nacional de Salud Pública · MXCentre International de Recherche sur le Cancer · FRHarvard University · USWinship Cancer Institute

Funding

World Health Organization 001
6 · The paper itself

Abstract

Low circulating levels of vitamin D and high mammographic density (MD) have been associated with higher risk of breast cancer. Although some evidence suggested an inverse association between circulating vitamin D and MD, no studies have investigated this association among Mexican women. We examined whether serum 25-hydroxyvitamin D3 [25(OH)D3] levels were associated with MD in a cross-sectional study nested within the large Mexican Teacher's Cohort. This study included 491 premenopausal women with a mean age of 42.9 years. Serum 25(OH)D3 levels were measured by liquid chromatography/tandem mass spectrometry. Linear regression and non-linear adjusted models were used to estimate the association of MD with serum 25(OH)D3. Median serum 25(OH)D3 level was 27.3 (23.3-32.8) (ng/ml). Forty one (8%) women had 25(OH)D3 levels in the deficient range (< 20 ng/ml). Body mass index (BMI) and total physical activity were significantly correlated with 25(OH)D3 (r = -0.109, P = 0.019 and r = 0.095, P = 0.003, respectively). In the multivariable linear regression, no significant association was observed between 25(OH)D3 levels and MD overall. However, in stratified analyses, higher serum 25(OH)D3 levels (≥27.3 ng/ml) were significantly inversely associated with percent MD among women with BMI below the median (β = -0.52, P = 0.047). Although no significant association was observed between serum 25(OH)D3 and percent MD in the overall population, specific subgroups of women may benefit from higher serum 25(OH)D3 levels.

Indexed as

Breast DensityAdultAgedBody Mass IndexCalcifediolCross-Sectional StudiesExerciseFemaleHomocysteineHumansLongitudinal StudiesMaleMammographyMexicoMiddle AgedRegression AnalysisCalcifediolHomocysteine

Identifiers

PMID27564705
PMCPMC5001725
OpenAlexW2517300537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.